Evidence map›Paper›PMID 23758766›Full record

ArticleRetrovirology2013

Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.

Vasudev R Rao, Ujjwal Neogi, Joshua S Talboom, Ligia Padilla, Mustafizur Rahman, Cari Fritz-French, Sandra Gonzalez-Ramirez, Anjali Verma, Charles Wood, Ruth M Ruprecht and 8 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. HIV-1 Vif protein sequence variations in South African people living with HIV and their influence on Vif-APOBEC3G interaction.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Emerging concepts in the science of vaccine adjuvants.Nature reviews. Drug discovery · 2021
    Review
  13. Observational
  14. Article
  15. Opioid and neuroHIV Comorbidity - Current and Future Perspectives.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 4 countries.

Vasudev R RaoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Ujjwal Neogi
Joshua S Talboom
Ligia Padilla
Mustafizur Rahman
Cari Fritz-French
Sandra Gonzalez-Ramirez
Anjali Verma
Charles Wood
Ruth M Ruprecht
Udaykumar Ranga
Tasnim Azim
John Joska
Eliseo Eugenin
Anita Shet
Heather Bimonte-Nelson
William R Tyor
Vinayaka R Prasad
University of Nebraska–Lincoln · USAlbert Einstein College of Medicine · USAlzheimer's Association · USInternational Centre for Diarrhoeal Disease Research · BDJawaharlal Nehru Centre for Advanced Scientific Research · INSt.John's Medical College Hospital · INAtlanta VA Medical Center · USEmory University · USHarvard University · USUniversity of Cape Town · ZA

Funding

Virology and ImmunologyP01AI048240 · NIAID · UNIVERSITY OF WASHINGTON · PI RUPRECHT, RUTH MARGRIT · 2000 to 2020
$46.7M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
KAPOSIS SARCOMA AND HUMAN HERPESVIRUS IN AFRICAR01CA075903 · NCI · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 1998 to 2015
$11.1M
Supplement: Fogarty Training in HIV- and AIDS Associated Diseases/MalignanciesD43TW001429 · FIC · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2015
$7.2M
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDSR01MH096625 · NIMH · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI EUGENIN, ELISEO A · 2012 to 2020
$4.5M
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCHD43TW001403 · FIC · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 2000 to 2011
$3.8M
Nebraska Center for VirologyP30GM103509 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2012 to 2014
$3.3M
Dissecting the Role of HIV-1 Tat & Chemokine Axis in Subtype-Specificity of HADR01MH083579 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PRASAD, VINAYAKA R. · 2008 to 2012
$2.9M
Research Training in Comparative Viral PathogenesisT32AI060547 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2004 to 2013
$2.5M
Neuropathogenesis and Neuroinvasiveness of Subtype C Human Immunodeficiency VirusR01NS074903 · NINDS · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2011 to 2015
$1.7M
FIC NIH HHS D43 TW001403FIC NIH HHS D43 TW001429NCI NIH HHS R01 CA075903NIAID NIH HHS P01 AI048240NIAID NIH HHS P30 AI051519NIAID NIH HHS T32 AI060547NIGMS NIH HHS GM103509NIMH NIH HHS R01 MH083579NIMH NIH HHS R01 MH096625NINDS NIH HHS NS74903NINDS NIH HHS R01 NS074903
6 · The paper itself

Abstract

backgroundHIV-1 Clade C (Subtype C; HIV-1C) is responsible for greater than 50% of infections worldwide. Unlike clade B HIV-1 (Subtype B; HIV-1B), which is known to cause HIV associated dementia (HAD) in approximately 15% to 30% of the infected individuals, HIV-1C has been linked with lower prevalence of HAD (0 to 6%) in India and Ethiopia. However, recent studies report a higher prevalence of HAD in South Africa, Zambia and Botswana, where HIV-1C infections predominate. Therefore, we examined whether Southern African HIV-1C is genetically distinct and investigated its neurovirulence. HIV-1 Tat protein is a viral determinant of neurocognitive dysfunction. Therefore, we focused our study on the variations seen in tat gene and its contribution to HIV associated neuropathogenesis.

resultsA phylogenetic analysis of tat sequences of Southern African (South Africa and Zambia) HIV isolates with those from the geographically distant Southeast Asian (India and Bangladesh) isolates revealed that Southern African tat sequences are distinct from Southeast Asian isolates. The proportion of HIV - 1C variants with an intact dicysteine motif in Tat protein (C30C31) was significantly higher in the Southern African countries compared to Southeast Asia and broadly paralleled the high incidence of HAD in these countries. Neuropathogenic potential of a Southern African HIV-1C isolate (from Zambia; HIV-1C 1084i), a HIV-1C isolate (HIV-1 IndieC1) from Southeast Asia and a HIV-1B isolate (HIV-1 ADA) from the US were tested using in vitro assays to measure neurovirulence and a SCID mouse HIV encephalitis model to measure cognitive deficits. In vitro assays revealed that the Southern African isolate, HIV-1C 1084i exhibited increased monocyte chemotaxis and greater neurotoxicity compared to Southeast Asian HIV-1C. In neurocognitive tests, SCID mice injected with MDM infected with Southern African HIV-1C 1084i showed greater cognitive dysfunction similar to HIV-1B but much higher than those exposed to Southeast Asian HIV - 1C.

conclusionsWe report here, for the first time, that HIV-1C from Southern African countries is genetically distinct from Southeast Asian HIV-1C and that it exhibits a high frequency of variants with dicysteine motif in a key neurotoxic HIV protein, Tat. Our results indicate that Tat dicysteine motif determines neurovirulence. If confirmed in population studies, it may be possible to predict neurocognitive outcomes of individuals infected with HIV-1C by genotyping Tat.

Indexed as

AdultAfrica, SouthernAIDS Dementia ComplexAnimalsAsia, SoutheasternFemaleGenotypeHIV-1HIV InfectionsHumansMaleMiceMiddle AgedMolecular Sequence DataPrevalenceSequence Analysis, DNAtat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID23758766
PMCPMC3686704
OpenAlexW2147647246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.